Evidence map›Paper›PMID 35460095›Full record

ReviewAlimentary pharmacology & therapeutics2022

Review article: rethinking the "ladder" approach to reflux-like symptom management in the era of PPI "resistance" - a multidisciplinary perspective.

A Pali S Hungin, Carmelo Scarpignato, Laurie Keefer, Maura Corsetti, Foteini Anastasiou, Jean W M Muris, Juan M Mendive, Peter J Kahrilas

Open access · hybridAbstract readReview
In one paragraph

Review in Alimentary pharmacology & therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Assessment and treatment of reflux-like symptoms in the community: a multidisciplinary perspective.The British journal of general practice : the journal of the Royal College of General Practitioners · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 8 countries.

A Pali S HunginPrimary Care and General Practice, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0001-7275-8927
Carmelo ScarpignatoDepartment of Health Sciences, United Campus of Malta, Msida, Malta.
Laurie KeeferIcahn School of Medicine at Mount Sinai, New York City, New York, USA.
Maura CorsettiNIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.ORCID 0000-0003-2957-4684
Foteini Anastasiou4th Local Primary Care Team, Municipality Practice and Academic Practice of Heraklion, Crete, Greece.
Jean W M MurisDepartment of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Juan M MendiveLa Mina Primary Care Academic Centre, Catalan Health Institute, University of Barcelona, Barcelona, Spain.
Peter J KahrilasDivision of Gastroenterology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Icahn School of Medicine at Mount Sinai · USInstitut Català d'Ornitologia · ESMaastricht University · NLNewcastle University · GBNorthwestern University · USNottingham University Hospitals NHS Trust · GBScience and Technology Park of Crete · GRUniversity of Malta · MT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite widespread adoption of potent acid suppression treatment with proton pump inhibitors (PPI) for reflux-like symptoms, persistent symptoms are commonly reported in primary care and community studies.

aimsThis multidisciplinary review critically evaluates how the management of reflux-like symptoms could better reflect their multifactorial pathophysiology.

methodsA panel of experts (from general practice, gastroenterology and gastropsychology) attended a series of workshops to review current management and propose a framework for the provision of more individualised care.

resultsIt was agreed that the perceptual (as well as the physiological) causes of reflux-like symptoms should be considered at the start of management, not as a last resort when all else has failed. A short course of PPI is a pragmatic approach to address reflux-like symptoms, but equally important is counselling about the gut-brain axis and provision of symptom-specific behavioural interventions for those who show signs of somatisation, hypervigilance or co-existing disorders of gut-brain interaction. Other low-harm interventions such as lifestyle and dietary advice, should also be better integrated into care at an early stage. Multidisciplinary care management programmes (including dietary, weight loss, exercise and behavioural intervention) should be developed to promote greater self-management and take advantage of the general shift toward the use of remotely accessed health care resources.

conclusionsManagement of reflux-like symptoms should be adapted to reflect the advances in knowledge about the multifactorial aetiology of these symptoms, addressing both acid-related and behavioural components early in management. The time has come to treat the patient, not the "disease".

Indexed as

Gastroesophageal RefluxGeneral PracticeHumansLife StyleProton Pump InhibitorsProton Pump Inhibitors

Identifiers

PMID35460095
PMCPMC9324949
OpenAlexW4224317653

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.